What Are Transfer Factors And How Does 4Life Use Them?
Medicine can be classified as aiding and implementing health and wellbeing.
DSDefenders believes it adds great value to the practice of medical experts such as doctors, pharmacists, and nurses; it also provides much-needed relief to suffering patients.
Medicine helps address health issues, paves the way for their treatment, works towards prevention, aids medical research, and contributes to endless discoveries. Such discoveries and medical breakthroughs are essential in the evolution of society since they help lower the financial burden of sickness. Instead, they strengthen healthcare systems.
Transfer factors constitute one such breakthrough that 4Life has been working towards. But before we talk about the incredible work they’ve put in, we must understand what makes these factors are.
A transfer factor is a substance extracted from a human or animal with previously established immunity against a certain illness.
They can be classified as proteins generated by the cells found in our immune system. Human studies are few and far between as the technology is still new.
However, according to some, they can be used to treat yeast infections, herpes, chronic fatigue syndrome, and infections in children.
Furthermore, Alzheimer’s disease, diabetes, infertility, fibromyalgia, Behcet’s syndrome, autism, Wiskott-Aldrich syndrome, baldness, systemic lupus erythematosus, and chronic fatigue syndrome are also expected to be treated with transfer factors.
They can also treat skin disorders such as eczema, psoriasis, hives, and allergic dermatitis. Transfer factors that can treat different diseases are now being created in labs to aid medical research.
Transfer factors, according to researchers, can pass on immunity to individuals who need it. They are administered orally or as injections.
4Life has been developing transfer factors to treat many life-impairing diseases. Founded in 1998, 4Life is headed by husband and wife duo David and Bianca Lisonbee.
4Life Transfer Factors was built from the ground up and includes the 4 S’s Science, Success, Service, and Satisfaction.
These factors act as molecules that can help transfer immune memory and info from organisms to each other instead of vitamins, minerals, or herbs found in health food shops.
They use science to develop state-of-the-art products that lead them to success. They advocate for providing the finest services that lead to the satisfaction of their stakeholders.
4Life laboratories are outfitted with cutting-edge technology and a top-tier staff of scientists that formulate and develop their goods.
Hundreds of tests are performed on each product to verify efficacy and quality. Moreover, many of their goods are patented and validated by other parties.
The parent lymphocyte has a delayed-type hypersensitivity and cell-mediated immunity passed on to non-immune recipients that appear to act across species.
In animal models, transfer factors have been found to reduce tumor growth and raise peripheral blood T-lymphocyte numbers.
Preliminary human investigations indicate that they are well tolerated and may effectively treat herpes, acute infection in children, chronic fatigue syndrome, and candidiasis.
One research found that raising white blood cells and CD8 lymphocytes in HIV patients was helpful.
Transfer factors comprise several molecules that function antigen-specifically, while others have immunomodulatory properties.
MREG-1, a low molecular weight subfraction produced from DLE, has improved cell-mediated immunity.
In response to transfer factors, cells from both murine recipients and people treated for herpes zoster virus infection release gamma-interferon in vitro.
According to research, immune response genes influence the synthesis of these factors but not their immunologic function.
The research into transfer factors has been very in-depth by 4Life. Transfer factors may increase resistance to particular illnesses.
Transfer factors derived from people or cows are safe in adulthood. Some persons may get a fever because of them.
Transfer factors derived from humans or cows are safe when administered to adults as an injection. Some persons may get a fever because of them.
They may also induce some soreness and welling up at the injection site. A dose of transfer factor from humans specific for the varicella virus is administered to prevent shingles in children with leukemia.
The correct dose is calculated by the health practitioner administering the injection, depending on the child’s weight.
Human transfer factor can be administered as an injection and isn’t harmful when given to children above the age of 6. For babies up to 6 months, the transfer factor from cows is safer.
Developments are still being made, and 4Life is progressing toward these factors treating multiple diseases that were once considered incurable.
However, there is still a long way to go, and thus far, the following diseases have not been effective in treatment by transfer factors, but clinical research is still taking place to ensure that one day they can.
Acne
According to a preliminary study, the factor did not alleviate acne when administered as a shot beneath the skin.
Infections caused by AIDS
According to new research, taking transfer factors by mouth may aid persons with AIDS-related cryptosporidiosis.
Cryptosporidiosis is a one-celled organism (protozoa) illness that causes diarrhea, fever, and stomach pains. The cow transfer factor appears to ease symptoms.
Asthma
Transfer factors orally or injecting them into the muscle does not enhance clinical status or lung function in most asthma patients.
However, some data suggests that taking factors by mouth may minimize the requirement for steroid medicines in children with chronic asthma allergies.
Itchy, red skin
Transfer factor has been shown in tests to be useful in treating eczema. According to several studies, taking these treatments relieves symptoms. Other studies have found no advantage.
Cancer of the cervix
Early study indicates that administering transfer factor as an injection under the skin following cervical cancer surgery and radiation treatment lessens the likelihood of recurrence.
The syndrome of chronic tiredness
When administered as an injection into the muscle, the transfer factor does not help symptoms in persons with CFS. However, preliminary evidence shows that it may ease symptoms when taken orally.
Crohn’s disease
Early study indicates that injecting the factors into the muscle does not help Crohn’s disease.
Epilepsy
Early studies indicate that combining transfer factors with antiseizure medications – carbamazepine or primidone – lowers the number of seizures experienced in persons with epilepsy.
Hepatitis B
Transfer factor has been shown in trials to help treat hepatitis B.
According to certain research, these factors extracted from individuals with acute hepatitis B may effectively treat active hepatitis B infection. Other studies, however, have shown no advantage.
Herpes
Early research reveals that the transfer factor may help prevent the second bout of herpes simplex virus (HSV) ocular infections in persons who have previously had these illnesses.
These treatments have also proved successful in preventing recurrent genital or oral herpes.
HIV/AIDS
Early study indicates that taking an HIV-specific transfer factor by mouth does not reduce the development of HIV in persons who are simultaneously taking the HIV medicine zidovudine.
Hodgkin’s Lymphoma
According to a preliminary study, delivering transfer factor as an injection beneath the skin did not prevent infections in persons with Hodgkin’s disease.
HPV
Early study indicates that administering transfer factor as an injection under the skin does not help cure warts in HPV patients.
Leishmaniasis
Leishmaniasis is a parasite illness that causes skin sores. There is some indication that the factors extracted from individuals with antibodies for Leishmania – the parasite that causes leishmaniasis – can aid in the healing of difficult-to-heal leishmaniasis skin lesions.
Leukemia
According to a preliminary study, delivering factors as an injection beneath the skin did not promote recovery in persons with leukemia.
Mycosis Fungoides
Early studies indicate that injecting transfer factors into the muscle does not help mycosis fungoides.
Cancer of the nose and throat
Several trials have shown transfer factors to improve survival in persons with nose and throat cancer.
According to certain studies, injecting a factor with specialized action against the Epstein-Barr virus into the muscle enhances survival. Other studies have found no advantage.
Osteosarcoma
According to preliminary findings, delivering transfer factors as a shot beneath the skin did not increase survival or minimize tumor recurrence in persons with osteosarcoma.
Cancer of the prostate
According to a preliminary study, injecting transfer factors into the muscle may slow the growth of certain kinds of prostate cancer. But complete healing wasn’t proven.
Arthritis Rheumatoid
According to a preliminary study, delivering factors as an injection beneath the skin did not relieve arthritis in children under 16.
Wiskott-Aldrich
Wiskott-Aldrich syndrome is a hereditary disorder. Some studies show that the human transfer factor may help persons with Wiskott-Aldrich syndrome live longer lives.